MedTech Resources

De Novo device

NTX100 Tonic Motor Activation (NTX100 ToMAc) System

Noctrix Health, Inc. · Stimulator, Nerve, For Restless Legs Syndrome (QWD, Class II) · First FDA decision Apr 17, 2023, newest Apr 17, 2023

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

Breakthrough-designated

Device trials

1

Naming "NTX100 Tonic Motor"

MAUDE reports

0

Brand "NTX100 Tonic Motor", since 2015

PubMed studies

0

Mentioning "NTX100 Tonic Motor"

AI summary across all sources

Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "NTX100 Tonic Motor", any status and sponsor, newest update first.

Open in Trial Radar

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "NTX100 Tonic Motor", and for the whole product code for context.

This brand

0 reports: 0 malfunction, 0 injury, 0 death

Whole product code QWD

2 reports: 0 malfunction, 2 injury, 0 death

Newest reports for this brand

No MAUDE reports name this brand.

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recall in FDA's data is linked to these FDA numbers.

Published research

The most relevant PubMed records for "NTX100 Tonic Motor"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

No PubMed record mentions this device by name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.